Catalyst Wire Dossier Catalyst Wire Dossier

Narlaprevir/Ritonavir

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Narlaprevir/Ritonavir, covering 2018-12-19 to 2018-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b [Phase 2]

See pricing